CDEK
← All organizations

Haemonetics Corporation

For profitWebsite ↗

Also known as: HAEMONETICS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

May 1, 2004

First marketed drug

Oct 27, 2004

Last known activity

Sep 1, 2012

Timeline

1970s

  1. Jun 1, 1971

    Haemonetics Corporation— Founded

1990s

  1. Apr 1, 1996

    DHL Laboratories, Inc— Acquired

2000s

  1. Oct 27, 2004

    sodium chloride— Marketing Organization

  2. Nov 20, 2007

    Haemoscope Corporation— Acquired

  3. Apr 4, 2008

    Medicell— Acquired

  4. Apr 1, 2009

    Altivation Software— Acquired

  5. Apr 16, 2009

    Neoteric Technology— Acquired

2010s

  1. Apr 6, 2010

    Global Med Technologies— Acquired

  2. Apr 30, 2012

    Hemerus Medical— Acquired

Drugs by trial phase (11 distinct, 7 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (0 own, 1 via acquisition)

Other trials (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (7 direct, 7 total across the full acquisition tree)

Recent trials (5)

Details

Founded
Braintree, MA, US Jun 1, 1971
Last known activity
Sep 1, 2012